Non Hodgkin Lymphoma Incidence and Mortality by Year, Kings County (Brooklyn), 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 227 10.4 9.0-11.9 109 12.2 9.9-14.9 118 9.3 7.6-11.1 123 5.5 4.6-6.6 69 7.8 5.9-10.0 54 4.1 3.0-5.3
1977 222 9.9 8.6-11.4 119 12.7 10.4-15.4 103 8.0 6.5-9.7 103 4.7 3.8-5.8 53 5.9 4.3-7.8 50 3.9 2.9-5.2
1978 240 11.0 9.6-12.5 114 12.2 9.9-14.7 126 10.0 8.2-11.9 119 5.6 4.6-6.7 67 7.2 5.5-9.3 52 4.3 3.2-5.6
1979 257 12.6 11.0-14.3 124 15.2 12.5-18.2 133 10.9 9.0-12.9 132 6.6 5.5-7.9 66 8.1 6.2-10.3 66 5.6 4.3-7.1
1980 289 13.3 11.8-15.0 143 15.7 13.1-18.6 146 11.5 9.6-13.6 119 5.5 4.5-6.6 65 7.4 5.7-9.5 54 4.1 3.1-5.4
1981 256 11.7 10.3-13.3 126 14.4 11.9-17.3 130 10.1 8.4-12.0 126 5.8 4.8-6.9 58 7.1 5.3-9.2 68 5.1 3.9-6.5
1982 302 13.9 12.4-15.7 151 16.6 14.0-19.6 151 11.9 10.0-14.0 135 6.2 5.2-7.4 58 6.6 5.0-8.6 77 5.9 4.7-7.5
1983 283 13.3 11.8-15.0 136 15.6 13.0-18.6 147 11.6 9.8-13.7 153 7.2 6.1-8.5 80 9.2 7.2-11.5 73 5.9 4.6-7.5
1984 304 13.7 12.2-15.4 161 17.8 15.1-20.9 143 10.9 9.2-12.9 132 6.1 5.1-7.3 73 8.1 6.3-10.2 59 4.7 3.5-6.0
1985 343 15.4 13.8-17.2 179 20.1 17.1-23.4 164 12.3 10.4-14.3 163 7.4 6.3-8.7 92 10.6 8.5-13.1 71 5.4 4.2-6.9
1986 361 16.4 14.7-18.2 178 19.4 16.5-22.5 183 14.1 12.1-16.3 137 6.4 5.3-7.5 78 9.0 7.1-11.3 59 4.5 3.4-5.9
1987 322 14.6 13.1-16.4 160 18.0 15.2-21.1 162 12.2 10.4-14.3 132 6.2 5.1-7.3 69 7.7 6.0-9.8 63 4.9 3.8-6.4
1988 345 15.9 14.2-17.7 174 19.3 16.4-22.4 171 13.4 11.4-15.6 166 7.7 6.6-9.0 85 9.8 7.7-12.1 81 6.3 5.0-7.9
1989 340 16.0 14.3-17.8 199 22.6 19.4-26.0 141 11.2 9.4-13.3 156 7.4 6.2-8.6 90 10.4 8.3-12.8 66 5.3 4.1-6.7
1990 415 19.1 17.3-21.1 224 24.3 21.1-27.8 191 15.0 12.9-17.3 159 7.5 6.3-8.7 78 9.3 7.2-11.6 81 6.3 5.0-7.8
1991 400 18.6 16.8-20.6 202 23.4 20.2-27.0 198 15.2 13.2-17.6 159 7.4 6.3-8.7 83 9.0 7.1-11.2 76 6.0 4.7-7.5
1992 426 19.8 17.9-21.8 220 24.1 20.9-27.6 206 16.3 14.2-18.8 163 7.6 6.5-8.9 84 9.7 7.6-12.0 79 6.2 4.9-7.8
1993 380 17.6 15.8-19.4 206 22.8 19.7-26.2 174 13.6 11.7-15.8 163 7.6 6.4-8.8 86 10.1 8.1-12.5 77 5.9 4.6-7.4
1994 427 19.7 17.9-21.7 222 23.8 20.7-27.3 205 16.1 14.0-18.5 166 7.9 6.7-9.2 82 9.5 7.5-11.8 84 6.6 5.2-8.1
1995 436 20.1 18.2-22.1 239 25.7 22.5-29.2 197 15.4 13.3-17.8 146 6.8 5.8-8.0 76 8.7 6.8-11.0 70 5.5 4.3-6.9
1996 438 20.1 18.3-22.1 242 27.1 23.7-30.8 196 15.2 13.1-17.5 158 7.4 6.3-8.6 79 9.7 7.6-12.1 79 6.1 4.8-7.6
1997 445 20.5 18.7-22.5 211 23.4 20.3-26.9 234 18.1 15.9-20.6 188 8.7 7.5-10.0 77 8.8 6.9-11.1 111 8.5 7.0-10.2
1998 392 17.7 16.0-19.6 203 21.7 18.7-24.9 189 14.7 12.7-17.0 185 8.5 7.3-9.8 86 9.8 7.8-12.1 99 7.5 6.1-9.1
1999 438 19.4 17.6-21.3 204 21.6 18.7-24.8 234 17.7 15.5-20.2 142 6.4 5.4-7.5 62 6.9 5.2-8.8 80 5.9 4.7-7.4
2000 453 19.6 17.8-21.5 222 23.1 20.2-26.4 231 17.2 15.0-19.6 141 6.1 5.2-7.3 60 6.5 5.0-8.4 81 5.9 4.7-7.4
2001 423 18.1 16.5-20.0 224 22.9 20.0-26.2 199 14.7 12.7-16.9 148 6.4 5.4-7.5 81 8.7 6.9-10.9 67 4.7 3.6-6.0
2002 408 17.4 15.7-19.1 219 22.0 19.1-25.1 189 13.8 11.9-15.9 139 6.0 5.0-7.1 80 8.6 6.8-10.7 59 4.3 3.3-5.5
2003 432 18.3 16.6-20.2 228 23.0 20.0-26.2 204 15.0 13.0-17.2 118 5.0 4.2-6.0 65 6.9 5.3-8.8 53 3.8 2.8-4.9
2004 405 17.2 15.6-19.0 208 21.5 18.6-24.6 197 14.4 12.4-16.5 120 5.1 4.2-6.1 53 5.4 4.0-7.1 67 4.8 3.7-6.1
2005 472 19.9 18.2-21.8 237 23.7 20.8-27.0 235 17.2 15.0-19.6 137 5.8 4.9-6.8 72 7.8 6.1-9.8 65 4.5 3.5-5.8
2006 429 18.2 16.5-20.0 212 21.1 18.3-24.1 217 15.9 13.9-18.2 121 5.3 4.4-6.3 55 6.0 4.5-7.8 66 4.9 3.8-6.3
2007 472 19.9 18.1-21.8 249 25.0 21.9-28.3 223 16.3 14.2-18.6 130 5.4 4.5-6.5 62 6.4 4.9-8.2 68 4.8 3.7-6.1
2008 471 19.4 17.7-21.3 251 24.4 21.4-27.7 220 15.7 13.7-18.0 115 4.9 4.0-5.9 58 6.1 4.6-8.0 57 4.0 3.0-5.2
2009 501 20.7 18.9-22.6 248 24.1 21.1-27.4 253 17.9 15.7-20.3 135 5.6 4.7-6.7 63 6.4 4.9-8.2 72 5.1 3.9-6.4
2010 458 18.7 17.0-20.5 232 22.2 19.4-25.3 226 15.9 13.8-18.1 132 5.5 4.6-6.5 67 7.0 5.4-8.9 65 4.4 3.4-5.7
2011 518 20.7 18.9-22.6 255 23.7 20.9-26.9 263 18.1 16.0-20.5 134 5.3 4.5-6.3 62 5.9 4.5-7.6 72 4.9 3.8-6.2
2012 510 19.8 18.1-21.6 275 25.4 22.4-28.6 235 16.1 14.1-18.4 115 4.5 3.7-5.4 67 6.4 5.0-8.2 48 3.1 2.3-4.1
2013 500 19.1 17.5-20.9 248 22.0 19.3-25.0 252 16.8 14.8-19.1 139 5.5 4.6-6.5 69 6.7 5.2-8.6 70 4.6 3.6-5.8
2014 526 19.7 18.0-21.5 287 24.9 22.1-28.0 239 15.7 13.7-17.8 116 4.4 3.6-5.2 52 4.9 3.6-6.4 64 4.1 3.1-5.2
2015 467 17.3 15.7-19.0 240 20.1 17.6-22.9 227 14.7 12.9-16.8 96 3.7 3.0-4.5 49 4.8 3.5-6.4 47 3.0 2.2-4.0
2016 523 19.1 17.5-20.9 271 22.8 20.1-25.8 252 16.3 14.3-18.6 119 4.5 3.7-5.3 58 5.2 3.9-6.7 61 3.9 3.0-5.0
2017 562 20.8 19.1-22.6 302 26.0 23.1-29.1 260 17.0 14.9-19.2 124 4.5 3.7-5.4 59 5.2 3.9-6.7 65 4.0 3.1-5.1
2018 510 18.5 16.9-20.2 271 22.6 20.0-25.5 239 15.3 13.4-17.5 91 3.3 2.6-4.0 48 4.3 3.1-5.7 43 2.5 1.8-3.4
2019 510 18.4 16.8-20.1 285 23.6 20.9-26.6 225 14.2 12.4-16.2 126 4.4 3.6-5.2 72 6.0 4.7-7.6 54 3.2 2.4-4.3
2020 452 16.3 14.8-17.9 231 19.3 16.8-22.0 221 14.0 12.2-16.1 95 3.3 2.7-4.1 48 4.0 3.0-5.4 47 2.8 2.0-3.7

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.